SOURCE: Wiley Systems, Inc.

Bioidentical Hormones

October 16, 2009 18:23 ET

Wiley Systems, Inc. Announces Two New Rhythmic Protocols at National Community Pharmacists Association (NCPA) 2009 Convention in New Orleans

Pharmacists Will Meet Author T.S. Wiley, Who Has Pioneered the Standardization of the Patent Pending Wiley Protocol® Rhythmic, Compounded Bioidentical Hormones, at Booth 636

SANTA BARBARA, CA--(Marketwire - October 16, 2009) - Wiley Systems™, Inc. announces the company will be exhibiting at Booth #636 at the 111th Annual Convention and Trade Exposition at the Ernest N. Morial Convention Center, New Orleans, Louisiana from October 17-21, 2009. The company will also announce two new Wiley Protocol® rhythms, Snooz™ - Seasonal Neuroendocrine Optimal Organizational Zeitgeber; Melatonin, and Sparc™ Therapy - Seasonal Pulsatile Adrenal Recalibration; Cortisol capsules.

T.S. Wiley is the developer of the Wiley Protocol rhythmic, compounded bioidentical hormones, and has pioneered the standardization of the patent pending Wiley Protocol and includes standardization of formulation, compounding procedure and color-coded packaging available to physicians and patients at recommended retail prices. The company's biomimetic hormone protocols must be formulated by a trained and registered compounding pharmacist.

A once-a-year opportunity, the NCPA convention provides exhibits, networking, and entertainment along with more than 20 hours of original and topical continuing education, enabling the nation's independent community pharmacists to sharpen their patient care skills and improve business performance throughout the following year.

"The NCPA is an important audience for Wiley Protocol, just as the Wiley Protocol is becoming increasingly important to community compounding pharmacists," said Dana Nelson, and Pharm. B.S., Pharm., M.S. and pharmacist in charge of Wiley Systems, Inc. "There are more than two million women in the U.S. who use customized hormones for menopause symptoms, and there are more than 47 million women who are in menopause. This means big business potential for compounding pharmacies." For details, pharmacists can view an interview with Dana Nelson regarding the compounding of the Wiley Protocol.

T.S. Wiley's mission is that any woman, in any city or town, could pick-up her prescription for the Wiley Protocol and it would be exactly the same as every other woman's, everywhere else. Wiley Systems' policy for quality control utilizes a pharmacist national review board, the Wiley Pharmacy Consortium, to insure complete standardization in all matters concerning methods, materials, formularies, patient inserts and diagnostic calendars. This is called the Wiley Systems Consortium Review Board (WSCRB), and includes the following registered pharmacies.

Wiley Systems, Inc. distributes the following biomimetic dosing schedules: The Wiley Protocol™ for Women; Wiley Protocol for Men™, biomimetic DHEA and testosterone restoration; Wiley Protocol Thyroid™ for Women, biomimetic thyroid hormone restoration; Wiley Protocol Testosterone™ for Women, biomimetic testosterone restoration; and Wiley Protocol Face Crème™, which promotes a more youthful appearance by filling in fine lines with the body's own adiposities.

To learn more online, visit or go to the Bioidenticals Network on YouTube where you may watch and listen to patients, pharmacists and doctors talk about their experiences with the Wiley Protocol.

T.S. Wiley is a medical theorist in environmental endocrinology and Darwinian medicine, and has residences in both Santa Fe, New Mexico and Santa Barbara, California. She is a noted writer, researcher and lecturer on the effects of hormones, particularly in menopausal women as well as an accepted expert in chronobiology and circadian rhythmicity. Wiley's environmental endocrinology seminars, "Two Days Back on Earth" in Glendale, California are attended by physicians from around the world.

About The National Community Pharmacists Association (NCPA)

The National Community Pharmacists Association, founded in 1898, represents the nation's community pharmacists, including the owners of more than 23,000 pharmacies. The nation's independent pharmacies, independent pharmacy franchises, and independent chains dispense nearly half of the nation's retail prescription medicines. To learn more go to the NCPA Web site.

About Wiley Systems, Inc. and the Wiley Protocol

Wiley Systems, Inc. was founded in 2005 in Santa Barbara, California by T.S. Wiley, who is the developer of the Wiley Protocol®, a trademarked patent pending delivery system consisting of the biomimetic, bioidentical hormones estradiol and progesterone, or biomimetic hormone restoration therapy. Wiley Systems began as a project to fund the union of doctors and pharmacists in a common goal to standardize bioidentical hormones for academic research. Now in 2009, the Wiley Pharmacy Consortium numbers around 50 pharmacies and more than 250 doctors prescribing in the US and Canada.

The Wiley Protocol is only available at compounding pharmacies that have joined the project for future National Institutes of Health (NIH) study and have contractually agreed to the standardized methods, materials, packaging and recommended pricing. In exchange, Wiley Systems provides intellectual property and provides 28WP logo-bearing packaging consisting of color-coded bags and applicators. The Wiley Protocol name assures customers they are receiving authentic Wiley Protocol dosing rhythms based on original research.

Contact Information